Open navigation
Search
Search
All expertise
Explore our breadth of expertise.
International Desks
Helping you access overseas markets with support from our country and region-specific experts.
Sectors View all
Practice Areas View all
Offices
Discover the scope of our presence in the jurisdiction.
Global Reach
Learn about our capabilities beyond borders.
CMS Netherlands
CMS Netherlands Abroad
All insights
Leverage our expert analysis, intelligence and thought leadership for your strategic advantage.
Personalised updates
Receive tailored insights and intelligence that apply directly to your business.
Topics in Focus View all
Insights by type
CMS News
Stay up to date with our growth, evolution and our many successes.
Press
Contact us
For all general enquiries.
About CMS
CMS Careers

Select your region

International Europe Africa Asia-Pacific The Americas Middle East
English Nederlands
Cilia Nierop

Cilia van Nierop

Advocaat

Amsterdam, Netherlands
Languages
  • Dutch
  • English
Social media

Cilia van Nierop is a member of the Commercial group of our firm in Amsterdam.

She is active in the Life Science & Healthcare sector. Cilia advises amongst others on a wide range a legal health issues, including eHealth, advertising / inducements, the healthcare contracting process, and other complex matters related to the healthcare system. She assists mainly private companies and also advises clients on compliance issues related to gaining market access for medical devices or medicines.

Cilia has been with CMS since November 2019, first as a paralegal during her Master's degree and since January 2021 as an attorney-at-law.

Education

  • Master Health law, 2020 (University of Amsterdam)
  • Bachelor Rechtsgeleerdheid, 2018 (Universiteit Utrecht)
Practice Areas
Commercial
sectors
Consumer Products Life Sciences & Healthcare

Insights by Cilia

See all Insights
Deals Netherlands

CMS advises Carl Zeiss Meditec AG on its acquisition of D.O.R.C.

18 Dec 2023 2 min read
Deals Netherlands

CMS advises T&S Groupe on the acquisition of TOPIC

07 Apr 2023 2 min read
Back to top Back to top
If you want to use third party tools, please enable personalisation cookies as part of your cookie preferences. You can change this setting at any time via the button below or in our Cookie Notice.